IGC Pharma (IGC) Finished Goods (2020 - 2026)
IGC Pharma (IGC) posted quarterly Finished Goods of $191000.0 for Q1 2026, down 25.39% year-over-year from $256000.0 in Q1 2025, and down 1.55% quarter-over-quarter from $194000.0 in Q4 2025.
IGC Pharma (IGC) Finished Goods (2020 - 2026) Analysis & Trends
IGC Pharma (IGC) has reported Finished Goods for 7 consecutive years, with $191000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Finished Goods fell 25.39% year-over-year to $191000.0; the TTM figure through Mar 2026 stood at $191000.0 (down 25.39% YoY), while the FY2026 annual figure was $191000.0, down 25.39% from the prior year.
- Finished Goods eased to $191000.0 in Q1 2026 per IGC's latest filing, from $194000.0 in the prior quarter.
- Across five years, Finished Goods topped out at $801000.0 in Q3 2022 and bottomed at $191000.0 in Q1 2026.
- Historically, Finished Goods has averaged $458705.9 across 5 years, with a median of $441000.0 in 2024.
- Annual changes were most pronounced in 2024 — Finished Goods slipped 17.26% — and 2025, when it plunged 47.52%.
- IGC Pharma's Finished Goods stood at $706000.0 in 2022, then decreased by 27.62% to $511000.0 in 2023, then retreated by 28.77% to $364000.0 in 2024, then sank by 46.7% to $194000.0 in 2025, then dropped by 1.55% to $191000.0 in 2026.
- Business Quant data shows IGC's Finished Goods at $191000.0 in Q1 2026, $194000.0 in Q4 2025, and $212000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 191,000.00 |
| Dec 31, 2025 | 194,000.00 |
| Sep 30, 2025 | 212,000.00 |
| Jun 30, 2025 | 271,000.00 |
| Mar 31, 2025 | 256,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 404,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 441,000.00 |
| Dec 31, 2023 | 511,000.00 |
| Sep 30, 2023 | 498,000.00 |
| Jun 30, 2023 | 550,000.00 |
| Mar 31, 2023 | 533,000.00 |
| Dec 31, 2022 | 706,000.00 |
| Sep 30, 2022 | 801,000.00 |
| Jun 30, 2022 | 752,000.00 |
| Mar 31, 2022 | 717,000.00 |
| Dec 31, 2021 | 889,000.00 |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 948,000.00 |